Skip to main content
Caplight Logo









Genencell Co., Ltd.

Genencell Co., Ltd.

Private
South KoreaHealthcare & Life Scienceshttp://genencell.co.kr/

Last Round

Convertible Debt

Oct 20, 2021

Total Funding Raised

$4.23M

Company Overview

Genencell Co., Ltd. is a biotechnology company that researches and develops medicines based on natural materials, health functional foods, and functional cosmetics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical Devices, Fashion & Beauty

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverynatural product therapeuticsclinical trialspharma licensinghealth functional foodsfunctional cosmeticsdiagnostic devicesbiotech startupbotanical medicinepharma R&Dnatural drug developmentbiotech venture

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genencell Co., Ltd. Comparables

Compare Genencell Co., Ltd. with similar companies based on industry and business-model similarity.

Genencell Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MThera Pharma
74%
Bichedam Co., Ltd.
67%
Mediforum Co., Ltd
66%

Genencell Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtOct 20, 2021
VC RoundFeb 3, 2021

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 20, 2021

    $4.23M round led by Sejong Medical Co., Ltd.

  • Feb 3, 2021

    $2.7M round led by KOREA PHARMA Co., Ltd.

Recent news

Latest coverage and updates

  • has_issues_withSep 8, 2026

    Genencell had issues with bribery allegations on Jul 1st '21.

Genencell Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Genencell Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Genencell Co., Ltd.'s valuation, stock price, and market status.

Is Genencell Co., Ltd. a public or private company?

Genencell Co., Ltd. is a private company.

What is the current stock price of Genencell Co., Ltd.?

Genencell Co., Ltd. is a private company with no public stock price. Caplight tracks Genencell Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Genencell Co., Ltd. worth (valuation)?

Valuation information for Genencell Co., Ltd. is not publicly available.

Can I buy Genencell Co., Ltd. stock?

Genencell Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Genencell Co., Ltd.'s last funding round?

Genencell Co., Ltd.'s most recent funding round was Convertible Debt on October 20, 2021.

Who are the main investors in Genencell Co., Ltd.?

Investor information for Genencell Co., Ltd. is not publicly disclosed.

Will Genencell Co., Ltd. IPO soon?

No public IPO plans have been announced for Genencell Co., Ltd..

How can I track Genencell Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genencell Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSouth Korea
Year Founded2017
Last FundingOct 20, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?